Toxicity of Chemotherapy Regimens in Advanced and Metastatic Pancreatic Cancer Therapy: A Network Meta ‐Analysis

This study demonstrated that the hematologic toxicity of S‐1 regimen was the lowest, while Gemcitabine regimen exhibited the lowest incidence rate of non‐hematologic toxicity, providing guidance for the treatment of advanced/metastatic PC. This article is protected by copyright. All rights reserved

Source: Journal of Cellular Biochemistry - July 6, 2017 Category: Biochemistry Authors: Xiao ‐Fang Wang, Wen‐Feng Huang, Jian Nie, Yong Zhou, Ding‐Wu Tan, Ji‐Hao Jiang Tags: Article Source Type: research